Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
23 02 2022
Historique:
pubmed: 10 2 2022
medline: 16 3 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

Resistance to oral antibiotics commonly used to treat outpatient urinary tract infections (UTIs) is increasing, but the implications of empirical treatment of resistant pathogens are not well described. Using an electronic records database, we reviewed the outcomes of patients >18 years of age who developed an outpatient UTI and had an outpatient urine culture result showing a member of the order

Identifiants

pubmed: 35138150
doi: 10.1128/spectrum.02359-21
pmc: PMC8826825
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0235921

Références

Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Diabetes Care. 2008 Jul;31(7):1380-5
pubmed: 18362200
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):359-361
pubmed: 29596402
BMJ. 2019 Feb 27;364:l525
pubmed: 30814048
PLoS Med. 2018 May 15;15(5):e1002569
pubmed: 29763434
Vital Health Stat 13. 2011 Apr;(169):1-38
pubmed: 21614897
JAMA. 2018 May 1;319(17):1781-1789
pubmed: 29710295
Open Forum Infect Dis. 2017 Feb 24;4(1):ofw281
pubmed: 28480273
N Engl J Med. 2012 Mar 15;366(11):1028-37
pubmed: 22417256
Ann Emerg Med. 2018 Oct;72(4):449-456
pubmed: 29980462
Am J Obstet Gynecol. 2021 Nov;225(5):550.e1-550.e10
pubmed: 34418350
J Urol. 2009 Dec;182(6 Suppl):S51-6
pubmed: 19846134
Am J Emerg Med. 2018 Jan;36(1):12-17
pubmed: 28655424
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654

Auteurs

Michael W Dunne (MW)

Iterum Therapeutics, Old Saybrook, Connecticut, USA.

Sailaja Puttagunta (S)

Iterum Therapeutics, Old Saybrook, Connecticut, USA.

Steven I Aronin (SI)

Iterum Therapeutics, Old Saybrook, Connecticut, USA.

Stephen Brossette (S)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

John Murray (J)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Vikas Gupta (V)

Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH